Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

498 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase III efficacy study of interleukin-3 after autologous bone marrow transplantation in patients with malignant lymphoma.
Brouwer RE, Vellenga E, Zwinderman KH, Bezwoda WR, Durrant ST, Herrmann RP, Kiese B, Maraninchi D, Milligan DW, Sklenar I, Tabilio A, Volonte JL, Winfield DA, Fibbe WE. Brouwer RE, et al. Among authors: vellenga e. Br J Haematol. 1999 Sep;106(3):730-6. doi: 10.1046/j.1365-2141.1999.01609.x. Br J Haematol. 1999. PMID: 10468866 Free article. Clinical Trial.
Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study.
Vellenga E, van Agthoven M, Croockewit AJ, Verdonck LF, Wijermans PJ, van Oers MH, Volkers CP, van Imhoff GW, Kingma T, Uyl-de Groot CA, Fibbe WE. Vellenga E, et al. Br J Haematol. 2001 Aug;114(2):319-26. doi: 10.1046/j.1365-2141.2001.02926.x. Br J Haematol. 2001. PMID: 11529850 Free article. Clinical Trial.
Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma.
Segeren CM, Sonneveld P, van der Holt B, Baars JW, Biesma DH, Cornellissen JJ, Croockewit AJ, Dekker AW, Fibbe WE, Löwenberg B, van Marwijk Kooy M, van Oers MH, Richel DJ, Schouten HC, Vellenga E, Verhoef GE, Wijermans PW, Wittebol S, Lokhorst HM. Segeren CM, et al. Among authors: vellenga e. Br J Haematol. 1999 Apr;105(1):127-30. Br J Haematol. 1999. PMID: 10233375 Free article. Clinical Trial.
Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease. a prospective randomised trial.
van Agthoven M, Vellenga E, Fibbe WE, Kingma T, Uyl-de Groot CA. van Agthoven M, et al. Among authors: vellenga e. Eur J Cancer. 2001 Sep;37(14):1781-9. doi: 10.1016/s0959-8049(01)00198-8. Eur J Cancer. 2001. PMID: 11549432 Clinical Trial.
Improved outcome of adult acute lymphoblastic leukaemia by moderately intensified chemotherapy which includes a 'pre-induction' course for rapid tumour reduction: preliminary results on 66 patients.
Daenen S, van Imhoff GW, van den Berg E, de Kam PJ, Haaxma-Reiche H, Vellenga E, Smit JW, Halie RM. Daenen S, et al. Among authors: vellenga e. Br J Haematol. 1998 Feb;100(2):273-82. doi: 10.1046/j.1365-2141.1998.00559.x. Br J Haematol. 1998. PMID: 9488613 Free article. Clinical Trial.
The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H, Mulder NH, Willemse PH, van der Graaf WT, Sleijfer DT, Zijlstra JG, Elias M, Sibinga CT, Vellenga E, de Vries EG. de Graaf H, et al. Among authors: vellenga e. Anticancer Res. 1995 Nov-Dec;15(6B):2851-6. Anticancer Res. 1995. PMID: 8669878
498 results